Efficacy and safety of acupuncture therapy for Parkinson's disease with neuropsychiatric symptoms: protocol for a systematic review and meta-analysis

被引:1
作者
Tan, Weiqiang [1 ]
Liu, Qing [2 ]
Cen, Mingjun [2 ]
Leong, Ian I. [2 ]
Pan, Zhaoquan [1 ]
Liao, Muxi [3 ]
Zhuang, Lixing [4 ]
机构
[1] Guangxi Univ Chinese Med, Nanning, Guangxi, Peoples R China
[2] Guangzhou Univ Chinese Med, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Univ Chinese Med Nanshan Dist, Shenzhen Nanshan Dist Chinese Med Hosp, Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[4] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
来源
BMJ OPEN | 2024年 / 14卷 / 05期
基金
中国国家自然科学基金;
关键词
Parkinson-s disease; Neurology; Adult psychiatry; DOPAMINE DYSREGULATION SYNDROME; QUALITY-OF-LIFE; DIAGNOSTIC-CRITERIA; NONMOTOR SYMPTOMS; DEPRESSION; MECHANISMS; PSYCHOSIS;
D O I
10.1136/bmjopen-2023-081041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Neuropsychiatric symptoms (NPS) are common non-motor symptoms among patients with Parkinson's disease (PD) and significantly impact their overall quality of life detrimentally. Several studies have reported the clinical effect of acupuncture therapy in treating NPS in PD. Therefore, the objective of this systematic review is to evaluate the potential inclusion of acupuncture therapy as an integral component of complementary treatment for PD with NPS.Methods and analysis From their inception until 1 December 2023, we will search eight databases, including PubMed, Cochrane Library, Embase, Web of Science, China National Knowledge Infrastructure, China Science Periodical Database, Chinese Citation Database and China Biology Medicine disc for randomised controlled trials examining the effectiveness of acupuncture for PD with NPS. Literature screening and data extraction will be carried out independently by the authors. RevMan V.5.3 software will be used for meta-analysis, while the Cochrane risk-of-bias tool will assess the potential for bias.Ethics and dissemination This systematic review protocol does not require ethical approval because it does not include private information or data of participants. This article will be published in a peer-reviewed journal.PROSPERO registration number CRD42022324494
引用
收藏
页数:5
相关论文
共 30 条
[1]   Neuropsychiatric Symptoms in Parkinson's Disease [J].
Aarsland, Dag ;
Kramberger, Milica Gregoric .
JOURNAL OF PARKINSONS DISEASE, 2015, 5 (03) :659-667
[2]   Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease [J].
Balestrino, Roberta ;
Martinez-Martin, Pablo .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 373 :173-178
[3]   A basic introduction to fixed-effect and random-effects models for meta-analysis [J].
Borenstein, Michael ;
Hedges, Larry V. ;
Higgins, Julian P. T. ;
Rothstein, Hannah R. .
RESEARCH SYNTHESIS METHODS, 2010, 1 (02) :97-111
[4]   SCHIZOPHRENIA AND DEPRESSION: A SYSTEMATIC REVIEW OF THE EFFECTIVENESS AND THE WORKING MECHANISMS BEHIND ACUPUNCTURE [J].
Bosch, Peggy ;
van den Noort, Maurits ;
Staudte, Heike ;
Lim, Sabina .
EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2015, 11 (04) :281-291
[5]  
Chinese Society of Neuropsychology and Behavioral Neurology Chinese Society of Parkinsons Disease and Movement Disorders, 2013, Chin J Neurol, V46, P56, DOI [10.3760/cma.j.issn.1006-7876.2013.01.015, DOI 10.3760/CMA.J.ISSN.1006-7876.2013.01.015]
[6]  
[中华医学会神经病学分会帕金森病及运动障碍学组 Chinese Society of Parkinson's Disease and Movement Disorders], 2021, [中华神经科杂志, Chinese Journal of Neurology], V54, P762
[7]  
[中华医学会神经病学分会帕金森病及运动障碍学组 Chinese Society of Parkinson's Disease And Movement Disorders], 2020, [中华神经科杂志, Chinese Journal of Neurology], V53, P973
[8]  
Dhanawat Meenakshi, 2020, Central Nervous System Agents in Medicinal Chemistry, V20, P88, DOI 10.2174/1871524920666200705222842
[9]   Dopamine dysregulation syndrome in Parkinson's disease [J].
Evans, AH ;
Lees, AJ .
CURRENT OPINION IN NEUROLOGY, 2004, 17 (04) :393-398
[10]  
Hasegawa Kazuko, 2012, Brain and Nerve (Tokyo), V64, P453